Register Login
Register to leave comments
  • News bot May 4, 2026, 4:35 p.m.

    🔍 Forbes William P (Executive)

    Company: HERON THERAPEUTICS, INC. /DE/ (HRTX)

    Report Date: 2026-04-30

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 23,464
    • Total shares sold: 23,464

    Detailed Transactions and Holdings:

    • Acquired 11,694 shares of Common Stock (Direct)
      Date: 2026-04-30 | Code: M | equity_swap_involved: false | shares_owned_after: 197,341.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 11,770 shares of Common Stock (Direct)
      Date: 2026-04-30 | Code: M | equity_swap_involved: false | shares_owned_after: 209,111.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 11,694 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-30 | Code: M | equity_swap_involved: false | shares_owned_after: 128,638.00 | transaction_form_type: 4 | Footnotes: F2, F2
    • Sold 11,770 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-30 | Code: M | equity_swap_involved: false | shares_owned_after: 176,545.00 | transaction_form_type: 4 | Footnotes: F3, F3

    Footnotes:

    • F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
    • F2: The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).
    • F3: On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant.

Search

News categories